Re: Berg et al.: Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol (Ophthalmology 2015;122:146... von Avery, Robert L., MD

Volltext

Incidence of Choroidal Neovascularization in the Fellow Eye in the Comparison of Age-related Macular Degeneration Treatments Trials von Maguire, Maureen G., PhD, Daniel, Ebenezer, MBBS, PhD, Shah, Ankoor R., MD, Grunwald, Juan E., MD, Hagstrom, Stephanie A., PhD, Avery, Robert L., MD, Huang, Jiayan, MS, Martin, Revell W., BA, Roth, Daniel B., MD, Castellarin, Alessandro A., MD, Bakri, Sophie J., MD, Fine, Stuart L., MD, Martin, Daniel F., MD

Volltext

Bevacizumab (Avastin) for retinopathy of prematurity: Wrong dose, wrong drug, or both? von Avery, Robert L., MD

Volltext

Systemic Safety of Prolonged Monthly Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema: A Systematic Review and Meta-analysis von Avery, Robert L, Gordon, Gabriel M

Volltext

Surgical Method for Implantation of a Biosynthetic Retinal Pigment Epithelium Monolayer for Geographic Atrophy: Experience from a Phase 1/2a Study von Kashani, Amir H., Uang, Jeremy, Mert, Melissa, Rahhal, Firas, Chan, Clement, Avery, Robert L., Dugel, Pravin, Chen, Sanford, Lebkowski, Jane, Clegg, Dennis O., Hinton, David R., Humayun, Mark S.

Volltext

What is the evidence for systemic effects of intravitreal anti-VEGF agents, and should we be concerned? von Avery, Robert L

Volltext

Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications von Tong, Zongzhong, Yang, Zhenglin, Patel, Shrena, Chen, Haoyu, Gibbs, Daniel, Yang, Xian, Hau, Vincent S, Kaminoh, Yuuki, Harmon, Jennifer, Pearson, Erik, Buehler, Jeanette, Chen, Yuhong, Yu, Baifeng, Tinkham, Nicholas H, Zabriskie, Norman A, Zeng, Jiexi, Luo, Ling, Sun, Jennifer K, Prakash, Manvi, Hamam, Rola N, Tonna, Stephen, Constantine, Ryan, Ronquillo, Cecinio C, Sadda, SriniVas, Avery, Robert L, Brand, John M, London, Nyall, Anduze, Alfred L, King, George L, Bernstein, Paul S, Watkins, Scott, Jorde, Lynn B, Li, Dean Y, Aiello, Lloyd Paul, Pollak, Martin R, Zhang, Kang

Volltext

Ranibizumab for the Treatment of Macular Edema Associated with Perfused Central Retinal Vein Occlusions von Pieramici, Dante J., MD, Rabena, Melvin, BS, Castellarin, Alessandro A., MD, Nasir, Ma'an, MD, See, Robert, MD, Norton, Tamara, MPH, Sanchez, Andres, Risard, Sarah, Avery, Robert L., MD

Volltext

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD von Avery, Robert L, Castellarin, Alessandro A, Steinle, Nathan C, Dhoot, Dilsher S, Pieramici, Dante Joseph, See, Robert, Couvillion, Stephen, Nasir, Ma'an A, Rabena, Melvin D, Le, Kha, Maia, Mauricio, Visich, Jennifer E

Volltext

The Plague and Macular Degeneration von Avery, Robert L., MD

Volltext

Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients With Age-Related Macular Degeneration Treated With Intravitreal Aflibercept or Ranibizumab von Parikh, Ravi, Avery, Robert L, Saroj, Namrata, Thompson, Desmond, Freund, K. Bailey

Volltext

Extrapolating anti-vascular endothelial growth factor therapy into pediatric ophthalmology: Promise and concern von Avery, Robert L., MD

Volltext

The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results von Khanani, Arshad M., Aziz, Aamir A., Khan, Hannah, Gupta, Ashwin, Mojumder, Ohidul, Saulebayeva, Aigerim, Abbey, Ashkan M., Almeida, David R. P., Avery, Robert L., Banda, Himanshu K., Barakat, Mark R., Bhandari, Ramanath, Chang, Emmanuel Y., Haug, Sara J., London, Nikolas J. S., Mein, Luke, Sheth, Veeral S., Wolfe, Jeremy D., Singer, Michael A., Danzig, Carl J.

Volltext

Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration von Avery, Robert L., Pieramici, Dante J., Rabena, Melvin D., Castellarin, Alessandro A., Nasir, Ma’an A., Giust, Matthew J.

Volltext

Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions von Wubben, Thomas J., Johnson, Mark W., Sohn, Elliott H., Peairs, James J., Kay, Christine N., Kim, Stephen J., Gardner, Thomas W., Paulus, Yannis M., Zacks, David N., Steinle, Nathan C., Avery, Robert L., Berrocal, Maria H.

Volltext

Retinal non-perfusion in diabetic retinopathy von Wykoff, Charles C., Yu, Hannah J., Avery, Robert L., Ehlers, Justis P., Tadayoni, Ramin, Sadda, SriniVas R.

Volltext

Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy von Avery, Robert L., Pearlman, Joel, Pieramici, Dante J., Rabena, Melvin D., Castellarin, Alessandro A., Nasir, Ma’an A., Giust, Matthew J., Wendel, Robert, Patel, Arun

Volltext

Long-term Follow-up of a Phase 1/2a Clinical Trial of a Stem Cell-Derived Bioengineered Retinal Pigment Epithelium Implant for Geographic Atrophy von Humayun, Mark S., Clegg, Dennis O., Dayan, Margot S., Kashani, Amir H., Rahhal, Firas M., Avery, Robert L., Salehi-Had, Hani, Chen, Sanford, Chan, Clement, Palejwala, Neal, Ingram, April, Mitra, Debbie, Pennington, Britney O., Hinman, Cassidy, Faynus, Mohamed A., Bailey, Jeffrey K., Johnson, Lincoln V., Lebkowski, Jane S.

Volltext

Vascular Endothelial Growth Factor Inhibitors for Diabetic Retinopathy von Dhoot, Dilsher S., Avery, Robert L.

Volltext

Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice von Heier, Jeffrey S, Bressler, Neil M, Avery, Robert L, Bakri, Sophie J, Boyer, David S, Brown, David M, Dugel, Pravin U, Freund, K. Bailey, Glassman, Adam R, Kim, Judy E, Martin, Daniel F, Pollack, John S, Regillo, Carl D, Rosenfeld, Philip J, Schachat, Andrew P, Wells, John A

Volltext